Tiffany Kary is a reporter at Bloomberg. She covers a range of topics including cannabis, social issues, drug trafficking, and developments in New York City. Her work has been featured in prominent publications such as The Washington Post, Fortune, and Bloomberg News, among others.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Tiffany Kary's coverage heavily focuses on the healthcare & pharmaceutical industry, with a specific emphasis on marijuana, cannabis, psychedelics, drug policy and research. Her articles also touch upon legal policy regulation and government announcements related to these topics.
Given her focus on the healthcare sector and drug-related issues like marijuana and psychedelics, Tiffany would likely be interested in receiving pitches from experts who can provide insights into regulatory changes impacting these industries or those involved in groundbreaking drug research.
She covers a range of topics within the broader context of healthcare & pharmaceuticals but largely centers around the impact of legislation and policies on businesses operating within this space. Therefore, sources with expertise in compliance, legal implications for businesses or health benefits/risks associated with drugs could be compelling for her reporting.
This information evolves through artificial intelligence and human feedback. Improve this profile .
(Bloomberg) -- New York State's sales of legal cannabis this year will pass the $200 million mark in early June as enforcement of illegal stores ramps up, according to the state's Office of Cannabis Management.
Flavored disposable vapes entering the US from China pose an unprecedented time and resource challenge to the US Food and Drug Administration , which says it needs more money and staff to crack down on them.
Flavored disposable vapes entering the US from China pose an unprecedented time and resource challenge to the US Food and Drug Administration, which says it needs more money and staff to crack down on them.
By: Sophia Vahanvaty, Tiffany Kary
The US Food and Drug Administration said Friday it’s allowing tobacco giant Altria Group Inc. to market four different menthol-flavored e-cigarettes, just two months after the Biden administration controversially delayed making a decision about banning menthol cigarette sales.
By: Tiffany Kary, Greg Stohr
(Bloomberg) -- The US Supreme Court said it will hear a Biden administration appeal that aims to reinforce the Food and Drug Administration's power to bar flavored vaping products it concludes are likely to appeal to children.
A slew of Zyn competitors are rushing in to capitalize on troubles at the Philip Morris-owned brand, which is facing a run on supply for its popular oral nicotine pouches and a subpoena that prompted a halt in its online sales in the US.
A slew of Zyn competitors are rushing in to capitalize on troubles at the Philip Morris-owned brand, which is facing a run on supply for its popular oral nicotine pouches and a subpoena that prompted a halt in its online sales in the US.
By: Tiffany Kary
A slew of Zyn competitors are rushing in to capitalize on troubles at the Philip Morris-owned brand, which is facing a run on supply for its oral nicotine pouches and a subpoena that prompted a halt in its online sales in the U.S.
By: Tiffany Kary
America's former No. 1 beer keeps losing ground since a conservative backlash last year. Now AB InBev is betting big on another light beer.
By: Sabah Meddings, Tiffany Kary
America’s former No. 1 beer keeps losing ground since a conservative backlash last year. Now AB InBev is betting big on another light beer.
(833) 317-6278 
